Anaplastic lymphoma kinase modulators and methods of use
Details for Australian Patent Application No. 2004259012 (hide)
International Classifications
Event Publications
16 February 2006 PCT application entered the National Phase
PCT publication WO2005/009389 Priority application(s): WO2005/009389
3 March 2011 Application Accepted
Published as AU-B-2004259012
30 June 2011 Standard Patent Sealed
15 March 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 20 Jan 2012. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2005
2 August 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 20 Jan 2012 2006
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004259011-Antiglucocorticoids for the treatment of catatonia
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser